Add
BGMD to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| BGMD > SEC Filings for BGMD > Form 8-K on 9-Aug-2012 | All Recent SEC Filings |
9-Aug-2012
Results of Operations and Financial Condition, Other Events, Financial Statemen
In a press release dated August 9, 2012 (the "earnings press release"), BG Medicine, Inc. (the "Company") announced financial results for the fiscal quarter ended June 30, 2012 and provided a business update. A copy of the earnings press release is attached hereto as Exhibit 99.1. The information in the second and third paragraphs of the earnings press release, the information under the headings "Financial Results" and "Conference call and webcast" and the condensed consolidated financial information included in the earnings press release are incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.
In the earnings press release, the Company also provided a business update. The information set forth under the heading "Business Update" in the earnings press release, together with the forward-looking statement disclaimer at the end of the earnings press release, is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.
(d) Exhibits.
99.1 Earnings press release dated August 9, 2012.
The portions of the earnings press release incorporated by reference into Item 8.01 of this Current Report on Form 8-K are being filed pursuant to Item 8.01. The remaining portions of the earnings press release are being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that Section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
|
|